BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26881600)

  • 21. Histopathological characteristics of adult renal tumours: a preliminary report.
    Latif F; Mubarak M; Kazi JI
    J Pak Med Assoc; 2011 Mar; 61(3):224-8. PubMed ID: 21465932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma.
    Chapman-Fredricks JR; Herrera L; Bracho J; Gomez-Fernandez C; Leveillee R; Rey L; Jorda M
    Ann Diagn Pathol; 2011 Oct; 15(5):333-7. PubMed ID: 21665507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Clear Cell Renal Cell Carcinoma with Marked Intraluminal Mucin Secretion.
    Okcu O; Behzatoğlu K; Çakir Y; Paşaoğlu E; Yücetaş U
    Turk Patoloji Derg; 2019; 35(1):52-54. PubMed ID: 28272672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and classification of renal cell carcinoma.
    Bostwick DG; Eble JN
    Urol Clin North Am; 1999 Aug; 26(3):627-35. PubMed ID: 10494293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal Bellini's collecting duct carcinoma: report of a case].
    Wang W; Yu GH; Qu GM; Yao WD; Jiang L
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):631. PubMed ID: 21092594
    [No Abstract]   [Full Text] [Related]  

  • 26. Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy.
    Hew MN; Baseskioglu B; Barwari K; Axwijk PH; Can C; Horenblas S; Bex A; Rosette JJ; Pes MP
    J Urol; 2011 Jul; 186(1):42-6. PubMed ID: 21571340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multilocular cystic renal cell carcinoma].
    Lang ZQ; Yao WD; Qu GM; Jiang L
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):574-5. PubMed ID: 17134559
    [No Abstract]   [Full Text] [Related]  

  • 29. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
    Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
    J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal cell carcinoma with rhabdoid features and sarcomatoid change: a case report].
    Fukata S; Karashima T; Toi M; Kuroda N; Shuin T
    Hinyokika Kiyo; 2010 Apr; 56(4):221-3. PubMed ID: 20448446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clear cell renal cell carcinoma with neuroendocrine differentiation and liver metastasis: report of a case].
    Yang L; Mu D; Yuan Y; Zhang D; Sun J; Cai S; Gao Y
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):278-9. PubMed ID: 24915823
    [No Abstract]   [Full Text] [Related]  

  • 33. A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
    Sun M; Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Arjane P; Widmer H; Pharand D; Latour M; Perrotte P; Patard JJ; Karakiewicz PI
    Eur Urol; 2009 Nov; 56(5):775-81. PubMed ID: 19573980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer.
    Ozbek E; Calik G; Otunctemur A; Aliskan T; Cakir S; Dursun M; Somay A
    Arch Ital Urol Androl; 2012 Mar; 84(1):7-11. PubMed ID: 22649953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syncytial giant cell component. Review of 55 renal cell carcinomas.
    Berzal Cantalejo F; Sabater Marco V; Alonso Hernández S; Jiménez Peña R; Martorell Cebollada MA
    Histol Histopathol; 2004 Jan; 19(1):113-8. PubMed ID: 14702178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of simplified versions of the Fuhrman nuclear grading system in clinical practice requires the agreement of a multidisciplinary panel of experts.
    Ficarra V; Novara G; Martignoni G
    Eur Urol; 2009 Nov; 56(5):782-4; discussion 784-5. PubMed ID: 19660853
    [No Abstract]   [Full Text] [Related]  

  • 38. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unclassified renal cell carcinoma: impact on survival following nephrectomy.
    Crispen PL; Tabidian MR; Allmer C; Lohse CM; Breau RH; Blute ML; Cheville JC; Leibovich BC
    Urology; 2010 Sep; 76(3):580-6. PubMed ID: 20223503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unclassified renal cell carcinoma: a report of 56 cases.
    Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
    BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.